miRNA dysregulation is an emerging modulator of genomic instability

APF Cardoso, M Banerjee, AN Nail, A Lykoudi… - Seminars in cancer …, 2021 - Elsevier
Genomic instability consists of a range of genetic alterations within the genome that
contributes to tumor heterogeneity and drug resistance. It is a well-established characteristic …

Regulatory T cells in gastric cancer: Key controllers from pathogenesis to therapy

I Negura, M Pavel-Tanasa, M Danciu - Cancer Treatment Reviews, 2023 - Elsevier
Gastric cancer (GC) is a highly aggressive malignancy that remains a significant contributor
to cancer-related mortality worldwide, despite a decline in incidence in recent years. Early …

[HTML][HTML] Origins and consequences of chromosomal instability: From cellular adaptation to genome chaos-mediated system survival

CJ Ye, Z Sharpe, HH Heng - Genes, 2020 - mdpi.com
When discussing chromosomal instability, most of the literature focuses on the
characterization of individual molecular mechanisms. These studies search for genomic and …

[HTML][HTML] The SCF complex is essential to maintain genome and chromosome stability

LL Thompson, KA Rutherford, CC Lepage… - International Journal of …, 2021 - mdpi.com
The SKP1, CUL1, F-box protein (SCF) complex encompasses a group of 69 SCF E3
ubiquitin ligase complexes that primarily modify protein substrates with poly-ubiquitin chains …

[HTML][HTML] Overview of tumor heterogeneity in high-grade serous ovarian cancers

E Azzalini, G Stanta, V Canzonieri, S Bonin - International Journal of …, 2023 - mdpi.com
Ovarian cancers encompass a group of neoplasms originating from germinal tissues and
exhibiting distinct clinical, pathological, and molecular features. Among these, epithelial …

[HTML][HTML] Disentangling the roles of aneuploidy, chromosomal instability and tumour heterogeneity in developing resistance to cancer therapies

JR Andrade, AD Gallagher, J Maharaj… - Chromosome …, 2023 - Springer
Aneuploidy is defined as the cellular state of having a number of chromosomes that deviates
from a multiple of the normal haploid chromosome number of a given organism. Aneuploidy …

[HTML][HTML] HJURP promotes malignant progression and mediates sensitivity to cisplatin and WEE1-inhibitor in serous ovarian cancer

Z Dou, C Qiu, X Zhang, S Yao, C Zhao… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Ovarian cancer is the most lethal gynecological malignancy. Recurrence and
chemoresistance are tough challenges leading to poor prognosis. HJURP is a molecular …

[HTML][HTML] Chromosome instability is prevalent and dynamic in high-grade serous ovarian cancer patient samples

CR Morden, AC Farrell, M Sliwowski… - Gynecologic …, 2021 - Elsevier
Objective High-grade serous ovarian cancer (HGSOC) is the most lethal gynaecological
malignancy in women with a high level of mortality, metastatic disease, disease recurrence …

[HTML][HTML] Reduced RBX1 expression induces chromosome instability and promotes cellular transformation in high-grade serous ovarian cancer precursor cells

M Bungsy, MC Palmer, LM Jeusset, NM Neudorf… - Cancer Letters, 2021 - Elsevier
Despite high-grade serous ovarian cancer (HGSOC) being the most common and lethal
gynecological cancer in women, the early etiological events driving disease development …

[HTML][HTML] PROTACs: Current and Future Potential as a Precision Medicine Strategy to Combat Cancer

KA Rutherford, KJ McManus - Molecular Cancer Therapeutics, 2024 - AACR
Proteolysis targeting chimeras (PROTAC) are an emerging precision medicine strategy,
which targets key proteins for proteolytic degradation to ultimately induce cancer cell killing …